User experience of home-based AbC-19 SARS-CoV-2 antibody rapid lateral flow immunoassay test

Abstract The urgent need to scale up testing capacity during the COVID-19 pandemic has prompted the rapid development of point-of-care diagnostic tools such as lateral flow immunoassays (LFIA) for large-scale community-based rapid testing. However, studies of how the general public perform when usin...

Full description

Bibliographic Details
Main Authors: Min Jing, Raymond Bond, Louise J. Robertson, Julie Moore, Amanda Kowalczyk, Ruth Price, William Burns, M. Andrew Nesbit, James McLaughlin, Tara Moore
Format: Article
Language:English
Published: Nature Portfolio 2022-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-05097-y